Arrhythmia Prophylaxis after Coronary Artery Bypass Grafting: Regimens of Magnesium Sulfate Administration

Background: Arrhythmias are common after open heart surgery and may be related to hypomagnesaemia due to cardiopulmonary bypass. Although perioperative prophylactic Mg²⁺ administration may prevent arrhythmias after coronary artery bypass grafting (CABG), clear indications as well as the timing of Mg²⁺ substitution and dose regimen need to be clarified. Aim of this study was to evaluate the antiarrhythmic effects of Mg²⁺ infusion in patients who underwent elective CABG. Method: Ninety-seven patients who underwent elective CABG were divided in four Groups. In Group A 1 g of magnesium sulfate was added to the pump prime, Group B received 1 g in the pump prime plus 5 mmol/L in the cardioplegic solution, Group C received 5 mmol/L in the cardioplegic solution, and Group D was a placebo control Group. Groups A, B, and C also received 24 h continuous infusion of magnesium sulfate at 10 mmol/L. Three-channel electrocardiogram (II-V₅-V₆) continuous monitoring was performed 12 hours preoperatively and 48 hours postoperatively. Blood samples were taken for subsequent Serum magnesium measurements, at five different time points before, during and after CBP. Results: In all Groups serum Mg²⁺ levels were reduced during CPB (Time 2) and statistically significant differences from pre-anaesthesia levels (Time 1) were noted (p < 0.05). In Groups A, B, and C Serum Mg²⁺ levels increased progressively from Time 3 to Time 5; in Group D serum Mg²⁺ levels were still much lower at Time 5. Significant differences (p < 0.05) were noted for Groups B and C vs Groups A and D in atrial ectopics, atrial fibrillation, and ventricular arrhythmic events. Conclusion: Our results demonstrate that Mg²⁺ sulfate administration regimens used in Group B and C reduce postoperative arrhythmic events in patients undergoing CABG.

Key words:

Coronary artery bypass surgery - Arrhythmias - Magnesium sulfate

References

• 1 White R E, Hartzell H C. Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes.  Science.. 1988;  239 778-80
• 2 Iseri L T, French J H. Magnesium: nature's physiologic calcium blocker.  Am Heart J.. 1984;  108 188-93
• 3 Nishio A, Gebrewold A, Altura B. Comparative effects of magnesium salts on reactivity of arterioles and veniles to constrictor agents: an in situ study on microcirculation.  J Pharmacol Exp Ther.. 1988;  246 859-65
• 4 Fantidis P, Stiris T A, Blanco D, Jarabo R M, Del Cerro M J, Ruiz M A. Effect of magnesium sulfate administration an subendocardial and subepicardial perfusion.  Biol Trace Elem Res.. 1997;  60 227-34
• 5 Carpentier R G, Posner P, Bloom S. Sinoatrial automaticity and transmembrane potentials in hamsters on a magnesium-deficient diet.  J Cardiovasc Pharm.. 1985;  7 919-23
• 6 Abraham A S, Rosenmann D, Kramer M. et al . Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction.  Arch Intern Med.. 1987;  147 753-55
• 7 Eisenberg M J. Magnesium deficiency and cardiac arrhythmia.  N Y State J Med.. 1986;  86 133-6
• 8 England M R, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double blind, randomized trial.  JAMA.. 1992;  268 2395-402
• 9 Morton B C, Nair R C, Smith F M, McKibbon T G, Poznaski W J. Magnesium therapy in acute myocardial infarction: a double blind study.  Magnesium.. 1984;  3 345-52
• 10 Rasmussen M S, Suenson M, McNair P, Norregrad P, Balsev S. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double blind placebo controlled study.  Clin Cardiol.. 1987;  10 351-6
• 11 Schwieger I, Kopel M E, Finlayson D C. Magnesium reduces the incidence of postoperative dysrhythmias in patients after cardiac surgery [Abstract].  Anesthesiology.. 1989;  71 A1162
• 12 Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction.  Am J Cardiol.. 1990;  66 271-74
• 13 Rasmussen H S, Norregrad P, Lindeneg O, McNair P, Backer V, Blaslev S. Intravenous magnesium in acute myocardial infarction.  Lancet.. 1986;  1 234-35
• 14 Rasmussen H S, Gronbaek M, Cintin C, Balslov S, Norregard P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo.  Clin Cardiol.. 1988;  11 377-81
• 15 Siddiqui M N, Zafar H, Alvi R. Hypomagnesaemia in postoperative patients: an important contributing factor in postoperative mortality.  Int J Clin Pract.. 1998;  52 265-7
• 16 Zaman A G, Alamgir F, Richens T, Williams R, Rothman M T, Mills P G. The role of signal averaged P wave duration and Serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery.  Heart.. 1997;  77 527-31
• 17 Satur C M. Magnesium and cardiac surgery.  Ann R Coll Surg Engl.. 1997;  79 349-54
• 18 Fanning W J, Thomas C S Jr, Roach A, Tomichek R, Alford W C, Stoney W S Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting.  Ann Thorac Surg.. 1991;  52 529-33
• 19 Hobbs W J, Fitchet A, Cotter L. Atrial arrhytmias after cardiac surgery [letter; comment].  N Engl J Med.. 1997;  337 860-1
• 20 Gerts S D, Wajnberg R S, Kurgan A, Uretzky G. Effect of magnesium sulfate an thrombus formation following partial arterial constriction: Implications for coronary vasospasm.  Magnesium.. 1987;  6 225-35
• 21 Horner S M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality: meta-analysis of magnesium in acute myocardial infarction.  Circulation.. 1992;  86 774-79
• 22 Ho K M. Atrial tachyarrhythmia after cardiac surgery: role of magnesium Infusion [letter]. Intensive Care Med. 1999: 25
• 23 Pearson P J, Evora P R, Seccombe J F, Schaff H V. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective rote of magnesium infusion after cardiac operations.  Ann Thorac Surg.. 1998;  65 967-72